AU6764501A - Cyclic urea compounds and preparation thereof - Google Patents

Cyclic urea compounds and preparation thereof

Info

Publication number
AU6764501A
AU6764501A AU6764501A AU6764501A AU6764501A AU 6764501 A AU6764501 A AU 6764501A AU 6764501 A AU6764501 A AU 6764501A AU 6764501 A AU6764501 A AU 6764501A AU 6764501 A AU6764501 A AU 6764501A
Authority
AU
Australia
Prior art keywords
compounds
carbamic acid
new
function
urea compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU6764501A
Other languages
English (en)
Inventor
Marc Rodriguez
Gilles Guichard
Serge Plaue
Vincent Semetey
Arnaud-Pierre Schaffner
Jean-Paul Briand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEOSYSTEM
RODRIGUE MARIE CHRISTINE GALAS
RODRIGUE ROMAIN
Centre National de la Recherche Scientifique CNRS
Original Assignee
NEOSYSTEM
RODRIGUE MARIE CHRISTINE GALAS
RODRIGUE ROMAIN
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEOSYSTEM, RODRIGUE MARIE CHRISTINE GALAS, RODRIGUE ROMAIN, Centre National de la Recherche Scientifique CNRS filed Critical NEOSYSTEM
Publication of AU6764501A publication Critical patent/AU6764501A/xx
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D255/00Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D255/00Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/04Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D259/00Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Fats And Perfumes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU6764501A 2000-06-13 2001-06-13 Cyclic urea compounds and preparation thereof Pending AU6764501A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0007507A FR2810039B1 (fr) 2000-06-13 2000-06-13 Composes urees cycliques et leur procede de preparation
PCT/FR2001/001837 WO2001096318A1 (fr) 2000-06-13 2001-06-13 Composes urees cycliques et leur procede de preparation

Publications (1)

Publication Number Publication Date
AU6764501A true AU6764501A (en) 2001-12-24

Family

ID=8851208

Family Applications (2)

Application Number Title Priority Date Filing Date
AU6764501A Pending AU6764501A (en) 2000-06-13 2001-06-13 Cyclic urea compounds and preparation thereof
AU2001267645A Ceased AU2001267645B2 (en) 2000-06-13 2001-06-13 Cyclic urea compounds and preparation thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001267645A Ceased AU2001267645B2 (en) 2000-06-13 2001-06-13 Cyclic urea compounds and preparation thereof

Country Status (13)

Country Link
US (1) US7186828B2 (https=)
EP (2) EP1640368A3 (https=)
JP (1) JP5054877B2 (https=)
KR (1) KR20030031001A (https=)
AT (1) ATE386728T1 (https=)
AU (2) AU6764501A (https=)
CA (2) CA2778314C (https=)
DE (1) DE60132891T2 (https=)
DK (1) DK1289968T3 (https=)
ES (1) ES2301554T3 (https=)
FR (1) FR2810039B1 (https=)
IL (1) IL153408A0 (https=)
WO (1) WO2001096318A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006331355B2 (en) * 2005-12-29 2011-09-29 Immupharma France Sa Compositions and methods for the inhibition of phospholipase A2
CA2635356C (en) * 2005-12-29 2011-11-01 Immupharma France Sa Use of 1,3,5-triazepin-2,6-diones to treat malaria
AU2006331357B2 (en) * 2005-12-29 2012-05-17 Immupharma France Sa Compositions and methods for synthesizing novel heterocyclic therapeutics
US7777030B2 (en) 2005-12-29 2010-08-17 Centre National de la Recherge Scientifique (CNRS) Compositions and methods for the treatment and prevention of disease
JP2009522236A (ja) * 2005-12-29 2009-06-11 イミュファルマ・フランス・エスアー マラリアまたはエイズの処置のためのアザ複素環化合物
US8563115B2 (en) 2008-08-12 2013-10-22 Xerox Corporation Protective coatings for solid inkjet applications
US8191992B2 (en) * 2008-12-15 2012-06-05 Xerox Corporation Protective coatings for solid inkjet applications
EP2548869A1 (en) * 2011-07-20 2013-01-23 Cytec Technology Corp. Process for the Synthesis of N-substituted Cyclic Alkylene Ureas
CN102911130B (zh) * 2011-08-03 2015-05-20 北京师范大学 一种一锅法合成脲四元环化合物的方法、合成的脲四元环化合物
AU2014310619B2 (en) 2013-08-21 2019-07-25 Centre National De La Recherche Scientifique (Cnrs) Peptide-oligourea chimeric compounds and methods of their use
WO2016207726A1 (en) 2015-06-22 2016-12-29 Ureka Sarl Bioinspired catalysis using oligourea helical foldamers
WO2017037142A1 (en) 2015-08-31 2017-03-09 Centre National De La Recherche Scientifique (Cnrs) Foldamer helix bundle-based molecular encapsulation
WO2017182873A2 (en) 2016-04-19 2017-10-26 Ureka Sarl Peptide-oligourea foldamer compounds and methods of their use
US12434075B2 (en) * 2021-05-11 2025-10-07 Celestial Oncology Inc. Coupled robotic radiation therapy system

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2847760A1 (de) * 1978-11-03 1980-05-14 Hoechst Ag Verfahren zur herstellung von 1,3,5-triaza-2,4,6-triketo-cycloheptan- 3,5-di-essigsaeureestern
US4918186A (en) * 1986-05-06 1990-04-17 Mitsui Toatsu Chemicals, Inc. Process for producing cyclic ureas
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
BR9206623A (pt) * 1991-10-11 1995-05-02 Du Pont Merck Pharma Uréias cíclicas e análogas úteis como inibidoras da protease retroviral
US5637780A (en) 1993-03-30 1997-06-10 The Dupont Merck Pharmaceutical Company Method for preparing alkylating agents and their use for alkylating cyclic ureas
US5508400A (en) * 1994-04-20 1996-04-16 The Du Pont Merck Pharmaceutical Company Preparation of cyclic urea compounds
AU5310096A (en) * 1995-03-17 1996-10-08 Du Pont Merck Pharmaceutical Company, The Cyclic urea hiv protease inhibitors
US5532356A (en) * 1995-06-06 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N,N'-disubstituted cyclic ureas
US5532357A (en) * 1995-06-07 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas
WO1997008150A1 (en) 1995-08-22 1997-03-06 The Du Pont Merck Pharmaceutical Company Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors
BR9712755A (pt) * 1996-11-08 1999-10-19 Du Pont Pharm Co Composto, composição farmacêutica, método para o tratamento de infecção por hiv e kit farmacêutico útil para o tratamento de infecção por hiv

Also Published As

Publication number Publication date
EP1640368A2 (fr) 2006-03-29
EP1289968A1 (fr) 2003-03-12
CA2778314A1 (en) 2001-12-20
US7186828B2 (en) 2007-03-06
JP2004503546A (ja) 2004-02-05
DK1289968T3 (da) 2008-06-23
US20040044199A1 (en) 2004-03-04
FR2810039B1 (fr) 2007-05-25
CA2412782A1 (en) 2001-12-20
WO2001096318A8 (fr) 2003-05-01
CA2778314C (en) 2017-01-03
FR2810039A1 (fr) 2001-12-14
DE60132891D1 (de) 2008-04-03
KR20030031001A (ko) 2003-04-18
ATE386728T1 (de) 2008-03-15
CA2412782C (en) 2012-08-07
IL153408A0 (en) 2003-07-06
AU2001267645B2 (en) 2006-07-27
DE60132891T2 (de) 2009-03-19
JP5054877B2 (ja) 2012-10-24
WO2001096318A1 (fr) 2001-12-20
ES2301554T3 (es) 2008-07-01
EP1289968B1 (fr) 2008-02-20
EP1640368A3 (fr) 2007-03-28

Similar Documents

Publication Publication Date Title
AU6764501A (en) Cyclic urea compounds and preparation thereof
FI950650A0 (fi) Retrovirusproteaasi-inhibiittoreina käyttökelpoisia hydroksietyyliaminosulfoniamideja
CA2081970A1 (en) Hiv protease inhibitors useful for the treatment of aids
HUP9902818A3 (en) Compounds with anti-inflammatory and immunosuppressive activities
CA2312935A1 (en) Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
WO2000062743A3 (en) Skin care compositions containing combination of skin care actives
GR3024495T3 (en) Cyclic peptides and use thereof
MY123740A (en) Il-13 receptor polypeptide
WO2000002987A3 (en) Amine reaction compounds comprising one or more active ingredient
DE69723728D1 (de) Totalsynthese des amino hip analogen von didemnin a
CA2237189A1 (en) 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
MXPA04004805A (es) Peptido novedoso que tiene un efecto inhibidor de la enzima convertidora de angiotensina.
BR9813817A (pt) Análogos de hemiasterlina
WO1998010786A3 (en) Pharmaceutical composition for the treatment of syndrome x of reaven
DE3850550D1 (de) Dipeptide, verwendbar als Pflanzenwachstumsregulatoren.
CO4560412A1 (es) Piperidonas
BR0011546A (pt) Lata de aço inoxidável para aerossóis dosadores acionados por propelente
DE69015451D1 (de) Enzym-inhibierende Peptid-Derivate.
AU682638B2 (en) Peptide, bronchodilator and blood flow ameliorant
CA2093202A1 (en) Sterilant gas mixture
ZA944106B (en) N-[[1-[4-(4-fluorophenoxy) butyl]-4-piperidinyl]-n-methyl-amino]-2-benzothiazolols as class III antiarrhythmic agents
WO2001051479A3 (en) Tricyclic compounds with antiviral activity
CA2109433A1 (en) Substituted benzhydrylamines as handles for solid phase peptide synthesis
NZ506667A (en) A process for the conversion of echinocandin class of peptides to their c4-homotyrosine monodeoxy analogues
NO952748D0 (no) Polypeptid som spesifikt inhiberer Cathepsin L.